Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

Press releases published on September 1, 2026

Sep. 1, 2026

Apps4Rent Delivers Secure Virtual Desktop Hosting Backed by SOC 2 Type II Infrastructure

Indeterminate EIN Presswire

Sep. 1, 2026

TOPDON USA to Donate 10% of September Product Sales to St. Jude Children’s Research Hospital®

Indeterminate EIN Presswire

Sep. 1, 2026

Admera Health Partners with AJIA to Expand Genomic Access for Early-Career Investigators

Indeterminate EIN Presswire

Sep. 1, 2026

Myridius Becomes an OpenAI Select Partner, Bringing Frontier AI to Enterprise Execution

Indeterminate EIN Presswire

Sep. 1, 2026

Behind Every Breakthrough: How Sampled Protects and Analyzes Irreplaceable Biological Samples

Indeterminate EIN Presswire

Sep. 1, 2026

Enovix’s TAA-Compliant Battery Manufacturing Strengthens Position with U.S. Defense Supply Chain

Indeterminate GlobeNewswire

Sep. 1, 2026

ZenaTech presentará el crecimiento de Drones como Servicio y las soluciones de defensa de ZenaDrone en una serie de eventos para inversionistas y de defensa en EE. UU. y en todo el mundo

Indeterminate GlobeNewswire

Sep. 1, 2026

Township of Raritan Partners with Solar Simplified to Offer Community Solar to Residents

Indeterminate EIN Presswire

Sep. 1, 2026

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Indeterminate GlobeNewswire

Sep. 1, 2026

Cerebras ja Compute Nordic Finland rakentavat uuden 165 megawatin datakeskuksen Mikkeliin

Indeterminate GlobeNewswire

Sep. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Indeterminate GlobeNewswire

Sep. 1, 2026

Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis annonce sa participation à plusieurs conférences investisseurs

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire